Dogwood Therapeutics, Inc.
DWTX
$1.94
-$0.10-4.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.75M | 6.50M | 6.10M | 9.86M | 10.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.53M | 28.60M | 27.97M | 31.70M | 18.20M |
| Operating Income | -29.53M | -28.60M | -27.97M | -31.70M | -18.20M |
| Income Before Tax | -38.49M | -28.29M | -34.04M | -38.02M | -24.55M |
| Income Tax Expenses | -2.45M | 31.70K | 221.00K | 188.70K | 190.10K |
| Earnings from Continuing Operations | -36.04 | -28.32 | -34.26 | -38.20 | -24.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.04M | -28.32M | -34.26M | -38.20M | -24.74M |
| EBIT | -29.53M | -28.60M | -27.97M | -31.70M | -18.20M |
| EBITDA | -29.53M | -28.58M | -27.93M | -31.67M | -15.86M |
| EPS Basic | -8.95 | -10.60 | -18.91 | -24.93 | -18.79 |
| Normalized Basic EPS | -5.47 | -6.63 | -8.53 | -12.05 | -8.21 |
| EPS Diluted | -8.95 | -10.60 | -18.91 | -24.93 | -18.79 |
| Normalized Diluted EPS | -5.47 | -6.63 | -8.53 | -12.05 | -8.21 |
| Average Basic Shares Outstanding | 84.11M | 51.90M | 19.79M | 6.58M | 5.77M |
| Average Diluted Shares Outstanding | 84.11M | 51.90M | 19.79M | 6.58M | 5.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |